← Medical directoryActive ingredient
Choriogonadotropin alfa
Recombinant chorionic gonadotropin (Ovitrelle). According to the summary of product characteristics in CIMA cited in the article, it is authorised in Spain to induce ovulation in women. Using it in men as 'post-cycle' therapy is off-label use.
Institutional endorsement by Clínica Evolution
This entry is for information. Your case requires an individual medical assessment.





